BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 17585915)

  • 41. Patterns of cervical cancer screening, diagnosis, and follow-up treatment in a state Medicaid fee-for-service population.
    Nadpara PA; Madhavan SS; Khanna R; Smith M; Miller LA
    Popul Health Manag; 2012 Dec; 15(6):362-71. PubMed ID: 22788858
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Awareness of cervical cancer, Papanicolau's smear and its utilization among female, final year undergraduates in Durban, South Africa.
    Hoque ME
    J Cancer Res Ther; 2013; 9(1):25-8. PubMed ID: 23575070
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Uptake of cervical cancer screening among the migrant population of Prato Province, Italy.
    Comparetto C; Epifani C; Manca MC; Lachheb A; Bravi S; Cipriani F; Bellomo F; Olivieri S; Fiaschi C; Di Marco L; Nardi V; Spinelli G; Borruto F
    Int J Gynaecol Obstet; 2017 Mar; 136(3):309-314. PubMed ID: 28099681
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The coverage of cervical screening in Hungary].
    Boncz I; Sebestyén A; Döbrossy L; Kovács A; Budai A; Székely T
    Orv Hetil; 2007 Nov; 148(46):2177-82. PubMed ID: 17988975
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cervical Cancer Screening and Incidence by Age: Unmet Needs Near and After the Stopping Age for Screening.
    White MC; Shoemaker ML; Benard VB
    Am J Prev Med; 2017 Sep; 53(3):392-395. PubMed ID: 28473240
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Knowledge, attitudes and practices of rural women in South Africa regarding the Pap smear.
    Lartey M; Joubert G; Cronje HS
    Int J Gynaecol Obstet; 2003 Dec; 83(3):315-6. PubMed ID: 14643048
    [No Abstract]   [Full Text] [Related]  

  • 47. Uptake of Pap smears among women in a large Israeli HMO between 2006 and 2008.
    Raz R; Shavit O; Stein M; Cohen R; Schejter E; Chodick G; Shalev V
    Public Health; 2012 Jul; 126(7):594-9. PubMed ID: 22657092
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of an extended free-of-fee strategy on the rate of cervical Papanicolaou smear screening in Israel.
    Froimovici M; Sulema V; Lurie S
    Int J Gynaecol Obstet; 2013 Feb; 120(2):127-30. PubMed ID: 23151372
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The coverage of cervical cancer screening in Khon Kaen, northeast Thailand.
    Kritpetcharat O; Suwanrungruang K; Sriamporn S; Kamsa-Ard S; Kritpetcharat P; Pengsaa P
    Asian Pac J Cancer Prev; 2003; 4(2):103-5. PubMed ID: 12875621
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A comparison of cervical cancer screening rates among women with traumatic spinal cord injury and the general population.
    Guilcher SJ; Newman A; Jaglal SB
    J Womens Health (Larchmt); 2010 Jan; 19(1):57-63. PubMed ID: 20088659
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Determinants of utilization of papanicolaou smear among outpatient clinic attendees in north-eastern Nigeria.
    Bukar M; Takai IU; Audu BM
    Afr J Med Med Sci; 2012 Jun; 41(2):183-9. PubMed ID: 23185917
    [TBL] [Abstract][Full Text] [Related]  

  • 52. No increased risk for cervical cancer after a broader definition of a negative Pap smear.
    Rebolj M; van Ballegooijen M; van Kemenade F; Looman C; Boer R; Habbema JD
    Int J Cancer; 2008 Dec; 123(11):2632-5. PubMed ID: 18767046
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The need to incorporate routine cervical cancer counselling and screening in the management of women at the outpatient clinics in Nigeria.
    Dim CC; Nwagha UI; Ezegwui HU; Dim NR
    J Obstet Gynaecol; 2009 Nov; 29(8):754-6. PubMed ID: 19821672
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Accuracy of Screening Tools for Pap Smears in General Practice.
    Harding C; Seal A; Pilotto L; Mackey K; Duncan G; Huynh R; McWilliam R; Blake S
    J Innov Health Inform; 2016 Sep; 23(3):835. PubMed ID: 28059690
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Screening for cervical cancer by Pap smear.
    Rizvi JH; Hasan S; Rasul S; Ghazali B; Jamal A
    J Pak Med Assoc; 1988 Sep; 38(9):229-31. PubMed ID: 3149319
    [No Abstract]   [Full Text] [Related]  

  • 56. Trend in cervical cancer screening in Spain (2003-2009) and predictors of adherence.
    Martín-López R; Hernández-Barrera V; de Andres AL; Carrasco-Garrido P; de Miguel AG; Jimenez-Garcia R
    Eur J Cancer Prev; 2012 Jan; 21(1):82-8. PubMed ID: 22129658
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gynecological care of elderly women. Another look at Papanicolaou smear testing.
    Mandelblatt J; Gopaul I; Wistreich M
    JAMA; 1986 Jul; 256(3):367-71. PubMed ID: 3723723
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Using probabilistic record linkage methods to identify Australian Indigenous women on the Queensland Pap Smear Register: the National Indigenous Cervical Screening Project.
    Whop LJ; Diaz A; Baade P; Garvey G; Cunningham J; Brotherton JM; Canfell K; Valery PC; O'Connell DL; Taylor C; Moore SP; Condon JR
    BMJ Open; 2016 Feb; 6(2):e009540. PubMed ID: 26873047
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cervical cytology screening in Vietnamese asylum seekers in a Hong Kong detention center. Population demographics and historical perspectives.
    Chang AR; Sewell H
    Acta Cytol; 2002; 46(3):475-80. PubMed ID: 12040640
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Improving cervical cytology screening in a remote, high risk population.
    Shield PW; Nolan GR; Phillips GE; Cummings MC
    Med J Aust; 1999 Mar; 170(6):255-8. PubMed ID: 10212646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.